Long-term structural failure of coaxial polyurethane implantable cardioverter defibrillator leads

被引:37
作者
Hauser, RG
Cannom, D
Hayes, DL
Parsonnet, V
Hayes, J
Ratliff, N
Tyers, GFO
Epstein, AE
Vlay, SC
Furman, S
Gross, J
机构
[1] Minneapolis Heart Inst Fdn, Minneapolis, MN USA
[2] Good Samaritan Hosp, Los Angeles, CA USA
[3] Mayo Clin, Rochester, MN USA
[4] Newark Beth Israel, Newark, NJ USA
[5] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI USA
[6] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[7] Univ Alabama Birmingham, Birmingham, AL USA
[8] Univ Hosp Stony Brook, Stony Brook, NY USA
[9] Montefiore Med Ctr, Bronx, NY 10467 USA
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 2002年 / 25卷 / 06期
关键词
implantable cardioverter defibrillator; leads; complications; registry;
D O I
10.1046/j.1460-9592.2002.t01-1-00879.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Transvene models 693616966, a coaxial polyurethane ICD lead, may be prone to structural failure. These models comprise 54% of ICD lead failures in the authors' Multicenter Registry database. Because ICD leads perform a vital function, the clinical features, causes, and probability of Transvene 693616966 lead failure were determined. The Registry and United States Food and Drug Administration databases were queried for the clinical features and structural causes of the Transvene 693616966 lead failure, and a five-center substudy estimated the survival probability for 521 Transvene 6936/6966 implants. The mean time to failure was 4.8 +/- 2.1 years, and the estimated survival at 60 and 84 months after implant were 92% and 84%, respectively. Oversensing was the most common sign of failure (76%), and 24 patients experienced inappropriate shocks. The manufacturer's reports indicated that high voltage coil fracture and 80A polyurethane defects were the predominant causes of lead failure. Transvene models 6936 and 6966 coaxial polyurethane ICD leads are prone to failure over time. Patients who have these leads should be evaluated frequently, Additional studies are needed to identify safe management strategies.
引用
收藏
页码:879 / 882
页数:4
相关论文
共 50 条
  • [11] Prospective Assessment of Linox Implantable Cardioverter Defibrillator Leads for Structural or Electrical Abnormalities
    Nicholas A. McKeag
    Rebecca L. Noad
    Kyle Ashfield
    Carol M. Wilson
    David J. McEneaney
    Michael J. D. Roberts
    Advances in Therapy, 2018, 35 : 666 - 670
  • [12] Implantable cardioverter-defibrillator in Brugada syndrome: Long-term follow-up
    El-Battrawy, Ibrahim
    Roterberg, Gretje
    Liebe, Volker
    Ansari, Uzair
    Lang, Siegfried
    Zhou, Xiaobo
    Borggrefe, Martin
    Akin, Ibrahim
    CLINICAL CARDIOLOGY, 2019, 42 (10) : 958 - 965
  • [13] Use of the implantable cardioverter-defibrillator in long-term survivors of orthotopic heart transplantation
    Ptaszek, LM
    Wang, PJ
    Hunt, SA
    Valantine, H
    Perlroth, M
    Al-Ahmad, A
    HEART RHYTHM, 2005, 2 (09) : 931 - 933
  • [14] Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT
    Poole, Jeanne E.
    Olshansky, Brian
    Mark, Daniel B.
    Anderson, Jill
    Johnson, George
    Hellkamp, Anne S.
    Davidson-Ray, Linda
    Fishbein, Daniel P.
    Boineau, Robin E.
    Anstrom, Kevin J.
    Reinhall, Per G.
    Packer, Douglas L.
    Lee, Kerry L.
    Bardy, Gust H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (04) : 405 - 415
  • [15] Intermuscular technique for implantation of the subcutaneous implantable cardioverter defibrillator: long-term performance and complications
    Winter, Joachim
    Siekiera, Markus
    Shin, Dong-In
    Meyer, Christian
    Kroepil, Patric
    Clahsen, Harald
    O'Connor, Stephen
    EUROPACE, 2017, 19 (12): : 2036 - 2041
  • [16] Long-term follow-up of adult patients with congenital heart disease and an implantable cardioverter defibrillator
    Cruz, Madalena Coutinho
    Monteiro, Andre Viveiros
    Portugal, Guilherme
    Laranjo, Sergio
    Lousinha, Ana
    Valente, Bruno
    Osorio, Paulo
    Cunha, Pedro Silva
    de Sousa, Lidia
    Oliveira, Jose Alberto
    Agapito, Ana
    Oliveira, Mario Martins
    Pinto, Fatima
    Ferreira, Rui Cruz
    CONGENITAL HEART DISEASE, 2019, 14 (04) : 525 - 533
  • [17] Implantable transvenous cardioverter defibrillator leads: The dark side
    Lawton, JS
    Wood, MA
    Gilligan, DM
    Stambler, BS
    Damiano, RJ
    Ellenbogen, KA
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1996, 19 (09): : 1273 - 1278
  • [18] Long-term longevity and clinical outcomes of Linox S/SD implantable cardioverter-defibrillator leads: a single-center experience
    Alasti, Mohammad
    Machado, Colin
    Mirzaee, Sam
    Healy, Stewart
    Bittinger, Logan
    Adam, David
    Kotschet, Emily
    Krafchek, Jack
    Alison, Jeffrey
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2021, 61 (01) : 115 - 121
  • [19] Riata implantable cardioverter-defibrillator lead failure: Analysis of explanted leads with a unique insulation defect
    Hauser, Robert G.
    McGriff, Deepa
    Retel, Linda Kallinen
    HEART RHYTHM, 2012, 9 (05) : 742 - 749
  • [20] Analysisof early failure of Biotronik Linox Smart implantable cardioverter-defibrillator leads: A comparative study of three defibrillator leads
    Perez Diez, Diego
    Manuel Rubin, Jose
    Calvo Cuervo, David
    Garcia Iglesias, Daniel
    Moris De La Tassa, Cesar
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2018, 41 (09): : 1165 - 1170